| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,285 | 0,302 | 07:46 | |
| 0,285 | 0,302 | 07:37 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| COSMOS HEALTH Aktie jetzt für 0€ handeln | |||||
| Do | Cosmos Health Inc.: Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Marg | 1.354 | GlobeNewswire (Europe) | Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability
supported... ► Artikel lesen | |
| Do | Cosmos Health plans guidance update following 2025 results | 1 | Investing.com | ||
| 11.03. | Cosmos Health purchases $600,000 in Bitcoin for treasury | 4 | Investing.com | ||
| 11.03. | Cosmos Health Inc.: Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000 | 133 | GlobeNewswire (Europe) | CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the purchase... ► Artikel lesen | |
| 10.03. | Cosmos Health signs letter of intent for Greek pharmacy network | 2 | Investing.com | ||
| 10.03. | Cosmos Health Inc.: Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000 | 287 | GlobeNewswire (Europe) | CHICAGO, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced... ► Artikel lesen | |
| 24.02. | Cosmos Health appoints AI drug discovery expert to advisory board | 4 | Investing.com | ||
| 24.02. | Cosmos Health Inc.: Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board | 593 | GlobeNewswire (Europe) | CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment... ► Artikel lesen | |
| 19.02. | Cosmos Health Inc.: Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value | 533 | GlobeNewswire (Europe) | CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today highlighted the intrinsic... ► Artikel lesen | |
| 18.02. | Cosmos Health: Hautreiniger C-Scrub bei britischer Kette Superdrug gelistet | 1 | Investing.com Deutsch | ||
| 18.02. | Cosmos Health's antimicrobial skin cleanser now available at Superdrug | 1 | Investing.com | ||
| 18.02. | Cosmos Health Inc.: Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer | 614 | GlobeNewswire (Europe) | CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued... ► Artikel lesen | |
| 18.02. | Cosmos Health's antimicrobial cleanser now available at Tesco | 3 | Investing.com | ||
| 18.02. | Cosmos Health Inc.: Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer | 598 | GlobeNewswire (Europe) | CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a significant... ► Artikel lesen | |
| 17.02. | Cosmos Health Inc.: Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026 | 835 | GlobeNewswire (Europe) | CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its participation... ► Artikel lesen | |
| 11.02. | Cosmos Health Inc.: Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies | 828 | GlobeNewswire (Europe) | CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the expansion... ► Artikel lesen | |
| 20.01. | Cosmos Health Inc.: Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue | 1.274 | GlobeNewswire (Europe) | CHICAGO, Jan. 20, 2026, a diversified, vertically integrated global healthcare group, today announced continued operational growth and infrastructure expansion at Cosmofarm, its pharmaceutical distribution... ► Artikel lesen | |
| 20.01. | Cosmos Health reports 20% customer growth at Greek subsidiary | 5 | Investing.com | ||
| 14.01. | Cosmos Health Inc.: Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research | 12 | GlobeNewswire (USA) | ||
| 05.01. | Cosmos Health: Aktie legt nach Produktionsvereinbarung mit Libytec zu | 7 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 31,800 | +0,76 % | Angriff auf Wegovy: 16 % Gewichtsverlust mit einer Pille schockt Novo-Nordisk-Anleger | © Foto: DALL*EEine Studie hat einen starken Gewichtsverlust mit einer experimentellen Tablette gezeigt. Analysten sehen Potenzial für einen neuen Rivalen im boomenden Abnehmmarkt. Die Aktie steigt.Der... ► Artikel lesen | |
| PFIZER | 23,135 | -0,62 % | 3 Charts in 3x33 Sekunden - Heute mit DAX, Palo Alto und Pfizer | 3 Charts in 3x33 Sekunden - Heute mit DAX, Palo Alto und Pfize ► Artikel lesen | |
| NOVARTIS | 126,60 | +0,56 % | Novartis-Aktie: Ist diese Übernahme wirklich gut? | Der Schweizer Pharmakonzern Novartis treibt den Ausbau seines Onkologiegeschäfts mit einer milliardenschweren Übernahme weiter voran: Für bis zu 3 Milliarden US-Dollar sichert sich das Unternehmen ein... ► Artikel lesen | |
| AURORA CANNABIS | 2,875 | +1,77 % | K-Tech Solutions Company Limited Announces Joint Venture with Aurora AZ Energy Ltd. to Develop up to 500 MW of AI and HPC Infrastructure in Canada | HONG KONG and NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- K-Tech Solutions Company Limited (Nasdaq: KMRK) ("K-Tech" or the "Company"), a technology firm specializing in high-performance computing infrastructure... ► Artikel lesen | |
| SANOFI | 77,07 | +0,30 % | BERENBERG stuft SANOFI auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Sanofi mit einem Kursziel von 105 Euro auf "Buy" belassen. Die Zurückhaltung der Anleger vor der Strategievorstellung des neuen Chefs bremse... ► Artikel lesen | |
| GSK | 22,400 | 0,00 % | BARCLAYS stuft GSK auf 'Underweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für GSK mit einem Kursziel von 1900 Pence auf "Underweight" belassen. Jüngste Absatzdaten belegten auf Wochensicht... ► Artikel lesen | |
| CANOPY GROWTH | 0,846 | +1,32 % | Cannabis-Boom 2026: Warum Bioxyne und Canopy jetzt das Spielfeld in Deutschland besetzen | ||
| STADA ARZNEIMITTEL | - | - | Pharmakonzern Stada legt zu dank Spezialmedikamenten | BAD VILBEL (dpa-AFX) - Der Arzneihersteller Stada hat 2025 auch dank eines starken Wachstums bei Spezialmedikamenten deutlich zugelegt. Im vergangenen Jahr stieg der bereinigte Umsatz zu konstanten... ► Artikel lesen | |
| ELI LILLY | 787,80 | +0,41 % | Eli Lilly unter Druck, Ausbruch nach unten | Die Eli Lilly-Aktie stand zuletzt nach einer Analystenabstufung im Fokus. Im Chartbild rückt nun vor allem die Reaktion auf zentrale Unterstützungsbereiche in den Vordergrund Den vollständigen Artikel... ► Artikel lesen | |
| MERCK & CO | 99,30 | +0,51 % | Merck Sharp & Dohme: Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL9 and GARDASIL at the EUROGIN International Multidisciplinary HPV Congress 2026 | Data show long-term effectiveness of GARDASIL9 and GARDASIL14 years and 18 years, respectively, following vaccination with 3 doses Data on certain HPV-related oropharyngeal cancers reinforce... ► Artikel lesen | |
| TILRAY BRANDS | 5,520 | +2,60 % | Monday newspaper round-up: Palantir, BrewDog, Darktrace | ||
| TEVA | 24,800 | -0,40 % | Teva Pharmaceutical Industries Ltd: Teva Releases Q1 2026 Aide Memoire | TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2026 Aide Memoire is available on the "Investors" page on its... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 385,30 | -1,96 % | VERTEX PHARMACEUTICALS INC in ruhiger Marktstruktur | ||
| INNOCAN PHARMA | 3,920 | 0,00 % | SCHOCKMELDUNG: InnoCan Pharma-Aktie in freiem Fall! | ||
| ABBOTT LABORATORIES | 90,11 | -1,41 % | Abbott's Volt Pulsed Field Ablation System zur Behandlung von Herzrhythmusstörungen ist jetzt in Deutschland verfügbar | Wiesbaden (ots) - - Das Volt[TM] Pulsed Field Ablation (PFA)-System von Abbott ist eine moderne Technologie, die Patient:innen eine neue, innovative Behandlungsoption bei Vorhofflimmern (AFib) bietet... ► Artikel lesen |